Attovia Therapeutics, Inc. (ATTO)
NGM · Healthcare · Biotechnology
$14.50
+2.26%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$661.9M
Shares Outstanding
45.7M
P/S (TTM)
1,471x
Exchange
NGM
Currency
USD
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 450K |
| Operating Income | (16.1M) | (16.6M) | (20.0M) | (21.8M) |
| Net Income | (15.2M) | (14.4M) | (18.7M) | (20.7M) |
| Diluted EPS | $-0.60 | $-0.56 | $-0.73 | $-0.48 |
Annual Financials
| Metric | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Revenue | 0.00 | 1.4M |
| Operating Income | (41.6M) | (67.2M) |
| Net Income | (39.8M) | (60.6M) |
| Diluted EPS | $-1.75 | $-2.37 |